Advertisement

Discussion on: Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome

Published:November 07, 2019DOI:https://doi.org/10.1016/j.amjsurg.2019.11.006
      DR. STEPHANIE VALENTE (Cleveland, Ohio): As we heard, the authors evaluated 88 patients with a strong family history of breast cancer who underwent genetic testing and were negative. They used the term “uninformed result” because physicians don’t know how to properly counsel or subsequently screen a patient with a strong family history and subsequent negative genetic results. The results of the study showed that there is a patient population at significant risk for developing breast cancer and that the uninformative result patient should be further explored to identify proper individualized high risk screening plan. Following the patients in this study long term to determine concordance between risk calculation and further development of breast cancer will be important.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Linked Article

      • Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome
        The American Journal of SurgeryVol. 219Issue 3
        • Preview
          The majority of women who undergo genetic testing due to a significant family history of breast cancer will receive a negative result. Using three widely used risk assessment models, we calculated lifetime breast cancer risks of women who had undergone genetic testing and received a negative result. We found that over half of the women included in the study were considered to be high-risk for the development of breast cancer.
        • Full-Text
        • PDF